Why Unfractionated Heparin Still Matters in Modern Anticoagulation – Thrombosis Canada
Thrombosis Canada shared a post on LinkedIn:
”Unfractionated heparin has been used for decades.
But using it well still requires careful clinical decisions.
When is UFH preferable to other anticoagulants?
Should treatment begin with a bolus?
When might a no – bolus strategy make more sense?
And how can the risks associated with UFH infusions be reduced?
At Thrombosis Unpacked: Decisions That Matter, Dr. Matthew Nicholson will take a modern look at this familiar anticoagulant in Unfractionated Heparin: Old Drug, Narrow Lane, focusing on where UFH still belongs in clinical practice and strategies to improve its safe use.
Join colleagues from across Canada to explore practical approaches to difficult thrombosis and anticoagulation decisions.
November 7, 2026 | Montréal.‘

Other posts featuring Thrombosis Canada on Hemostasis Today.
-
Nov 15, 2026, 23:44Pablo César Spada: Prevention of Venous Thromboembolism After Total Hip or Knee Replacement
-
Nov 15, 2026, 23:30Eshal Amir: Factor XI Inhibitors in AFib and Aortic Mortality Trends
-
Nov 15, 2026, 23:19Hamza Bashir: Adding Endovascular Therapy to Anticoagulation Cuts Moderate-to-Severe PTS in Half
-
Nov 15, 2026, 23:06Lanre Tunji-Ajayi: 2 Days of Deliberative Dialogue Hosted by the Network of Rare Blood Disorder Organizations
-
Nov 15, 2026, 23:00Fanny Delettre: Looking Back at Volunteer Blood Donor Friends Day
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines